Very-Low Nicotine Cigarettes and Non-Daily Smokers

NCT02228824 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 312

Last updated 2018-10-31

Study results available
· View outcomes & findings →

Summary

The purpose of this research study is to investigate the impact of different nicotine levels in cigarettes among non-daily smokers. This research may help inform the Food and Drug Administration (FDA) on how best to regulate tobacco products in the future, with the goal of improving public health.

Conditions

  • Smoking

Interventions

DRUG

Very low nicotine content cigarettes

0.07 mg nicotine delivery

DRUG

Normal nicotine content cigarettes

0.8 mg nicotine delivery

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • Saul Shiffman

    lead OTHER

Principal Investigators

  • Saul Shiffman, PhD · University of Pittsburgh, Department of Psychology

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2017-07-31
Completion
2017-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02228824 on ClinicalTrials.gov